Summary Safety Review - Finasteride - Assessing the Potential Risk of Serious Muscle-Related Side Effects (English, HTML)

View metadata and access the original English HTML file: Summary Safety Review - Finasteride - Assessing the Potential Risk of Serious Muscle-Related Side Effects.

Format

HTML

Access

file-only

Publisher-reported update

2024-05-09

Health Canada reviewed the risk of potential serious muscle-related side effects with finasteride use because of reports in which these events were seen in patients treated with Propecia and Proscar. The safety review focussed on potential risks of serious muscle-related adverse events such as rhabdomyolysis (pain in muscles with breakdown of muscle tissue and an increase in certain muscle proteins known as creatine kinase [CK] enzymes, myopathy (disease of muscles with pain and an increase in CK enzymes) and muscle disorders such as pain, weakness, atrophy (wasting) or stiffness.

Access original file